Common Medicines For Kidney Cancer Damage The Protein Structure – Part 1 of 3
Common Medicines For Kidney Cancer Damage The Protein Structure. The to a large used cancer drug bevacizumab (Avastin) is associated with a more than fourfold increased danger of severe urinary protein loss, a new review finds. This major loss of protein from the kidney into the urine can lead to significant kidney damage and reduce the effectiveness of the cancer drug, utter the researchers, who are from Stony Brook University Cancer Center in New York. The findings, culled from an analysis of 16 studies involving more than 12000 cancer patients, suggest that doctors indigence to monitor the kidney health of patients being treated with bevacizumab.
The report was released online June 10 in advance of publication in an upcoming print issue of the Journal of the American Society of Nephrology. In the review, 2,2 percent of the patients taking Avastin versed severe proteinura, with patients who were taking the highest doses of the drug facing an even higher risk. Also, the order of cancer played a role in the risk of kidney trouble, with kidney cancer patients seeing the greatest risk (10,2 percent).